Phone Icon

Current Active Cancer Care Clinical Trials

Cancer Clincial Trials Search Tips: The table below lists our current cancer clinical trials, organized by tumor type. You can use your browser's search tool (CTRL + F or Command + F) to find a clinical trial listing within this page. You can also use the search box at the very top of the website to find a particular clinical trial.

Tumor Type Protocol # Sponsor Title
Adrenal Cortical Carcinoma ARQ-087-101 ArQule Phase 1, dose escalation study of oral ARQ 087 for patients with advanced solid tumors
Adrenal Cortical Carcinoma MRX34-101 MiRNA A Multicenter Phase I Study of MRX34, MicroRNA miR-RX34 Liposome Injectable Suspension
Adrenal Cortical Carcinoma - FGFR Positive ARQ-087-101 ArQule Phase 1, dose escalation study of oral ARQ 087 for patients with advanced solid tumors
Anal Canal MK3475-028-00 Merck Study of MK-3475 in Participants With Advanced Solid Tumors (MK-3475-028/KEYNOTE-28)
Breast 673-301 BioMarin A Study Evaluating BMN 673, a PARP Inhibitor, in Advanced and/or Metastatic Breast Cancer Patients With BRCA Mutation
Breast M14-011 Abbvie A Randomized, Placebo-Controlled, Double-Blind, Phase 3 Study Evaluating Safety and Efficacy of the addition of Veliparib Plus Carboplatin Versus the Addition of Carboplatin to Standard Neoadjuvant chemotherapy Versus Standard Neoadjuvant Chemotherapy in Subjects with Early Stage Triple Negative Breast Cancer (TNBC)
Breast MK3475-028-00 Merck Study of MK-3475 in Participants With Advanced Solid Tumors (MK-3475-028/KEYNOTE-28)
Breast MM-398-01-01-02 Merimack A Pilot Study in Patients Treated With MM-398 to Determine Tumor Drug Levels and to Evaluate the Feasibility of Ferumoxytol Magnetic Resonance Imaging to Measure Tumor Associated Macrophages
Breast PMT4979g Genentech A Dose Escalation Study Evaluating the Safety and Tolerability of GDC-0032 in Patients With Locally Advanced or Metastatic Solid Tumors And in Combination With Endocrine Therapy in Patients With Locally Advanced or Metastatic Hormone Receptor-Positive Breast Cancer
Breast BRCA+ 673-301 BioMarin A Study Evaluating BMN 673, a PARP Inhibitor, in Advanced and/or Metastatic Breast Cancer Patients With BRCA Mutation
Breast TNBC EC1456-01 Endocyte Folic Acid-Tubulysin conjugate EC1456 in patients with advanced solid tumors
Breast TNBC M14-011 Abbvie A Randomized, Placebo-Controlled, Double-Blind, Phase 3 Study Evaluating Safety and Efficacy of the addition of Veliparib Plus Carboplatin Versus the Addition of Carboplatin to Standard Neoadjuvant chemotherapy Versus Standard Neoadjuvant Chemotherapy in Subjects with Early Stage Triple Negative Breast Cancer (TNBC)
Breast TNBC MM-398-01-01-02 Merimack A Pilot Study in Patients Treated With MM-398 to Determine Tumor Drug Levels and to Evaluate the Feasibility of Ferumoxytol Magnetic Resonance Imaging to Measure Tumor Associated Macrophages
Breast TNBC PCYC-1135-CA Pharmacyclics A Multi-Center Study of the Bruton's Tyrosine Kinase (BTK) Inhibitor, Ibrutinib, in Combination With MEDI4736, in Subjects With Relapsed or Refractory Solid Tumors.
Carcinoid MK3475-028-00 Merck Study of MK-3475 in Participants With Advanced Solid Tumors (MK-3475-028/KEYNOTE-28)
Cholangiocarcinoma ARQ-087-101 ArQule Phase 1, dose escalation study of oral ARQ 087 for patients with advanced solid tumors
Cholangiocarcinoma - FGFR Alterations ARQ-087-101 ArQule Phase 1, dose escalation study of oral ARQ 087 for patients with advanced solid tumors
Colon INCB 18424-267 Incyte A Randomized, Double-Blind Study of Ruxolitinib or Placebo in Combination With Regorafenib in Subjects With Relapsed or Refractory Metastatic Colorectal Cancer
Colon MINNELIDE 001 Minneamrita Study of Minnelide™ in Patients With Advanced GI Tumors
Colorectal INCB 18424-267 Incyte A Randomized, Double-Blind Study of Ruxolitinib or Placebo in Combination With Regorafenib in Subjects With Relapsed or Refractory Metastatic Colorectal Cancer
Colorectal SM04755-ONC-01 Samumed A Phase 1, Open-Label, Dose-Escalation, Dose-Finding Study Evaluating the Safety and Pharmacokinetics of SM04755 in Subjects with Advanced Colorectal, Gastric, Hepatic, or Pancreatic Cancer
Endometrial MK3475-028-00 Merck Study of MK-3475 in Participants With Advanced Solid Tumors (MK-3475-028/KEYNOTE-28)
Endometrial PMT4979g Genentech A Dose Escalation Study Evaluating the Safety and Tolerability of GDC-0032 in Patients With Locally Advanced or Metastatic Solid Tumors And in Combination With Endocrine Therapy in Patients With Locally Advanced or Metastatic Hormone Receptor-Positive Breast Cancer
Gastric MINNELIDE 001 Minneamrita Study of Minnelide™ in Patients With Advanced GI Tumors
Gastric SM04755-ONC-01 Samumed A Phase 1, Open-Label, Dose-Escalation, Dose-Finding Study Evaluating the Safety and Pharmacokinetics of SM04755 in Subjects with Advanced Colorectal, Gastric, Hepatic, or Pancreatic Cancer
GBM AG120-C-002 Agios Study of Orally Adminstered AG-120 in Subjects with Advanced Solid Tumors, Including Glioma, With an IDH1 Mutation
GIST - c-kit positive ARQ-087-101 ArQule Phase 1, dose escalation study of oral ARQ 087 for patients with advanced solid tumors
GIST - PDGFR Positive ARQ-087-101 ArQule Phase 1, dose escalation study of oral ARQ 087 for patients with advanced solid tumors
Glioblastoma multiforme (GBM) AG120-C-002 Agios Study of Orally Adminstered AG-120 in Subjects with Advanced Solid Tumors, Including Glioma, With an IDH1 Mutation
Glioma with IDH1 Mutation AG120-C-002 Agios Study of Orally Adminstered AG-120 in Subjects with Advanced Solid Tumors, Including Glioma, With an IDH1 Mutation
Glioma with IDH2 Mutation AG221-C-003 Celgene AG221-C-003Study of Orally Administered AG-221 in individuals With Advanced Solid Tumors, Including Glioma, and With Angioimmunoblastic T-cell Lymphoma, With an IDH2 Mutation
Head & Neck No current clinical trials available for this tumor type.
Hepatocellular MRX34-101 MiRNA A Multicenter Phase I Study of MRX34, MicroRNA miR-RX34 Liposome Injectable Suspension
Hepatocellular SM04755-ONC-01 Samumed A Phase 1, Open-Label, Dose-Escalation, Dose-Finding Study Evaluating the Safety and Pharmacokinetics of SM04755 in Subjects with Advanced Colorectal, Gastric, Hepatic, or Pancreatic Cancer
Kidney Cancer MRX34-101 MiRNA A Multicenter Phase I Study of MRX34, MicroRNA miR-RX34 Liposome Injectable Suspension
Lung No current clinical trials available for this tumor type.
Lung NSCLC PCYC-1135-CA Pharmacyclics A Multi-Center Study of the Bruton's Tyrosine Kinase (BTK) Inhibitor, Ibrutinib, in Combination With MEDI4736, in Subjects With Relapsed or Refractory Solid Tumors
Lung SCLC MK3475-028-00 Merck Study of MK-3475 in Participants With Advanced Solid Tumors (MK-3475-028/KEYNOTE-28)
Lung SCLC MRX34-101 MiRNA A Multicenter Phase I Study of MRX34, MicroRNA miR-RX34 Liposome Injectable Suspension
Lung SCLC PCYC-1135-CA Pharmacyclics A Multi-Center Study of the Bruton's Tyrosine Kinase (BTK) Inhibitor, Ibrutinib, in Combination With MEDI4736, in Subjects With Relapsed or Refractory Solid Tumors
Lymphoma ARQ-092-101 ArQule Phase 1 Study of ARQ 092 in patients with Advanced Solid Tumors and Recurrent Malignant Lymphoma
Lymphoma MRX34-101 MiRNA A Multicenter Phase I Study of MRX34, MicroRNA miR-RX34 Liposome Injectable Suspension
Lymphoma VS-5584-101 Verastem Phase I Dose Escalation Study of VS-5584 in Subjects With Advanced Non-Hematologic Malignancies or Lymphoma
Lymphoma - Angioimmunoblastic T-cell with IDH2 Mutation AG221-C-003 Celgene Study of Orally Administered AG-221 in individuals With Advanced Solid Tumors, Including Glioma, and With Angioimmunoblastic T-cell Lymphoma, With an IDH2 Mutation
Melanoma MRX34-101 MiRNA A Multicenter Phase I Study of MRX34, MicroRNA miR-RX34 Liposome Injectable Suspension
Melanoma BRAF+ No current clinical trials available for this tumor type.
Multiple Myeloma CC-90002-ST-001 Celgene A Phase 1, Open-label, Dose Finding Study of CC-90002, a Monoclonal Antibody Directed Against CD47, in Subjects With Advanced Solid and Hematologic Cancers
Nasopharyngeal No current clinical trials available for this tumor type.
Neuroendocrine DS6051-A-U101 Daiichi Phase I first in human study of DS-6051B; which is an oral ROS1 and NTRK inhibitor for individuals with advanced solid tumors
Neuroendocrine MK3475-028-00 Merck Study of MK-3475 in Participants With Advanced Solid Tumors (MK-3475-028/KEYNOTE-28)
Neuroendocrine MRX34-101 MiRNA A Multicenter Phase I Study of MRX34, MicroRNA miR-RX34 Liposome Injectable Suspension
Ovarian EC1456-01 Endocyte Folic Acid-Tubulysin conjugate EC1456 in patients with advanced solid tumors
Ovarian BRCA+ No current clinical trials available for this tumor type.
Pancreas ADU-CL-04 Aduro Efficacy of Combination Listeria/GVAX Immunotherapy in the Pancreatic Cancer Setting (ECLIPSE)
Pancreas GS-US-370-1369 Gilead A Phase 1b Study Evaluating Momelotinib Combined with Capecitabine and Oxaliplatin in Subjects with Relapsed/Refractory Metastatic Pancreatic Ductal Adenocarcinoma
Pancreas GS-US-385-1577 Gilead A Phase 1b Study of Single Agent Idelalisib Followed by Idelalisib in Combination With Chemotherapy in Subjects With Metastatic Pancreatic Ductal Adenocarcinoma.
Pancreas MINNELIDE 001 Minneamrita Study of Minnelide™ in Patients With Advanced GI Tumors
Pancreas NA 00090282 SU2C An Exploratory Study of Metformin With or Without Rapamycin as Maintenance Therapy after Induction Chemotherapy in Subjects with Metastatic Pancreatic Adenocarcinoma
Pancreas PBI-05204 Phoenix Biotechnology. Inc A Phase II, Single-arm, Open-label, Bayesian Adaptive Efficacy and Safety Study of PBI-05204 in Patients With Stage IV Metastatic Pancreatic Adenocarcinoma
Pancreas PCRT 12-001 Seena Nab-Paclitaxel+Cisplatin+Gemcitabine in Patients With Previously Untreated Metastatic Pancreatic Ductal Adenocarcinoma (PDA)
Pancreas PCYC-1135-CA Pharmacyclics A Multi-Center Study of the Bruton's Tyrosine Kinase (BTK) Inhibitor, Ibrutinib, in Combination With MEDI4736, in Subjects With Relapsed or Refractory Solid Tumors
Pancreas PLX119-01 Plexxikon Phase 1 Study of PLX7486 as Single Agent and With Gemcitabine Plus Nab-Paclitaxel in Patients With Advanced Solid Tumors
Pancreas SM04755-ONC-01 Samumed A Phase 1, Open-Label, Dose-Escalation, Dose-Finding Study Evaluating the Safety and Pharmacokinetics of SM04755 in Subjects with Advanced Colorectal, Gastric, Hepatic, or Pancreatic Cancer
Pancreas SU2C-007 SU2C 007 A Pharmacodynamic study of the Nab-Paclitaxel/Gemcitabine combo given weekly 3x as induction therapy followed by maintenance every 2 weeks in patients with metastatic pancreatic cancer
Pancreas BRCA+ No current clinical trials available for this tumor type.
Prostate EC1169-01 Endocyte A Phase 1 Study of a Prostate-Specific Membrane Antigen Targeting-Tubulysin conjugate EC1169 in Patients with recurrent metastatic, castration-resistant prostate cancer (mCRPC)
Prostate BRCA+ No current clinical trials available for this tumor type.
PVNS (Pigmented Villo-Nodular Synovitis) No current clinical trials available for this tumor type.
Rectal INCB 18424-267 Incyte A Randomized, Double-Blind Study of Ruxolitinib or Placebo in Combination With Regorafenib in Subjects With Relapsed or Refractory Metastatic Colorectal Cancer
Rectal MINNELIDE 001 Minneamrita Study of Minnelide™ in Patients With Advanced GI Tumors
Renal Cell Carcinoma MRX34-101 MiRNA A Multicenter Phase I Study of MRX34, MicroRNA miR-RX34 Liposome Injectable Suspension
Salivary Gland MK3475-028-00 Merck Study of MK-3475 in Participants With Advanced Solid Tumors (MK-3475-028/KEYNOTE-28)
Sarcoma No current clinical trials available for this tumor type.
Solid Tumor 391101 Baxter Phase 1 Study of Anti-Macrophage Migration Inhibitory Factor (Anti-MIF) Antibody in Solid Tumors
Solid Tumor 3V2640-CLIN-002 3-V Biosciences A Phase 1 study of the pill TVB-2640 in patients with any type of solid tumor
Solid Tumor AG221-C-003 Celgene Study of Orally Administered AG-221 in individuals With Advanced Solid Tumors, Including Glioma, and With Angioimmunoblastic T-cell Lymphoma, With an IDH2 Mutation
Solid Tumor Aldoxorubcin-P1-MTD-03 CytRx A Study to Investigate the Safety and Activity of Aldoxorubicin Plus Gemcitabine in Subjects With Metastatic Solid Tumors
Solid Tumor ARQ-092-101 ArQule Phase 1 Study of ARQ 092 in patients with Advanced Solid Tumors and Recurrent Malignant Lymphoma
Solid Tumor B7661001 Pfizer A First-in-human Phase 1, Dose Escalation, Safety And Pharmacokinetic Study Of Pf-06647020 In Adult Patients With Advanced Solid Tumors
Solid Tumor CC-486 CAGEN 001 Celgene A Phase 1 Study of CC-486 as a Single Agent and in Combination with Carboplatin or ABI-007 in Subjects with Relapsed or Refractory Solid Tumors
Solid Tumor CC-90002-ST-001 Celgene A Phase 1, Open-label, Dose Finding Study of CC-90002, a Monoclonal Antibody Directed Against CD47, in Subjects With Advanced Solid and Hematologic Cancers
Solid Tumor CLC-101 Cleave Biosciences, Inc. A Phase 1 Study Evaluating the Safety of Orally Administered CB-5083 in Patients With Advanced Solid Tumors
Solid Tumor DS6051-A-U101 Daiichi Phase I first in human study of DS-6051B; which is an oral ROS1 and NTRK inhibitor for individuals with advanced solid tumors
Solid Tumor EC1456-01 Endocyte Folic Acid-Tubulysin conjugate EC1456 in patients with advanced solid tumors
Solid Tumor M14-237 Abbvie A Dose-Escalation Study of ABBV-399, an Antibody Drug Conjugate, in Subjects With Advanced Solid Tumors
Solid Tumor M14-546 AbbVie A Phase 1 Study Evaluating the Safety and Pharmacokinetics of ABBV-075 in Subjects With Advanced Cancer
Solid Tumor PCYC-1135-CA Pharmacyclics A Multi-Center Study of the Bruton's Tyrosine Kinase (BTK) Inhibitor, Ibrutinib, in Combination With MEDI4736, in Subjects With Relapsed or Refractory Solid Tumors
Solid Tumor PLX119-01 Plexxikon Phase 1 Study of PLX7486 as Single Agent and With Gemcitabine Plus Nab-Paclitaxel in Patients With Advanced Solid Tumors
Solid Tumor PLX8394 Plexxikon A Phase I/IIa Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of PLX8394 in Patients With Advanced, Unresectable Solid Tumors
Solid Tumor VS-5584-101 Verastem Phase I Dose Escalation Study of VS-5584 in Subjects With Advanced Non-Hematologic Malignancies or Lymphoma
Solid Tumor HER2+ No current clinical trials available for this tumor type.
Solid Tumor with FGFR Alterations ARQ-087-101 ArQule Phase 1, dose escalation study of oral ARQ 087 for patients with advanced solid tumors
Solid Tumor with Liver Metastasis MRX34-101 MiRNA A Multicenter Phase I Study of MRX34, MicroRNA miR-RX34 Liposome Injectable Suspension
Solid Tumors with IDH1 Mutation AG120-C-002 Agios Study of Orally Adminstered AG-120 in Subjects with Advanced Solid Tumors, Including Glioma, With an IDH1 Mutation
Solid Tumors with IDH2 Mutation AG221-C-003 Celgene Study of Orally Administered AG-221 in individuals With Advanced Solid Tumors, Including Glioma, and With Angioimmunoblastic T-cell Lymphoma, With an IDH2 Mutation
Thyroid MK3475-028-00 Merck Study of MK-3475 in Participants With Advanced Solid Tumors (MK-3475-028/KEYNOTE-28)
Vulvar MK3475-028-00 Merck Study of MK-3475 in Participants With Advanced Solid Tumors (MK-3475-028/KEYNOTE-28)